MedStars, IncMedStars, Inc
Site map  
portfolio MedStars
Retrotope

Retrotope
URL: www.retrotope.com

Retrotope is developing pharmaceutical and nutritional products to increase cell resistance to oxidative attack to protect critical body tissues affected by generative disease such as Parkinson’s, Alzheimer’s, Macular Degeneration, congestive heart failure and others. Retrotope enriches atoms at specific locations in certain fatty acids and proteins with heavier isotopes, an universal chemical way to create stronger bonds—and in this case—cells that are more resistant to oxidative attack. Initial data shows both an ability to shut down oxidative stress, and increase longevity, in model organisms.



Robert Molinari is the CEO and co-founded Retrotope with Dr. Charles Cantor, a member of the US National Academy of Sciences, and Dr. Mikhail Shchepinov, the inventor of isotopic stabilization of essential dietary nutrients. Dr. Molinari has led angel financing rounds to allow the company to test its novel hypotheses on diseases and aging. He successfully led the effort to obtain grants animal trials in neurodegenerative disease.

see also
About Us
Contact Us

Contact Us
info@medstars.com
(650) 917-9254, 917-9256

  © 2009 MedStars. All rights reserved.
Design by Night River
medstars logo